Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Gary L Norman"'
Autor:
Andre Franke, Malgorzata Milkiewicz, Gary L. Norman, Christoph Schramm, Michael Mahler, Zakera Shums, Steffi Lopens, Piotr Milkiewicz, Marcin Krawczyk, Ewa Wunsch, Chelsea Bentow, Dirk Roggenbuck, Dirk Reinhold
Publikováno v:
Alimentary Pharmacology & Therapeutics
Background Primary sclerosing cholangitis (PSC) is associated with progressive liver disease and cholangiocarcinoma. Although risk stratification is crucial for making clinical decisions, it is hindered by a scarcity of proven prognostic markers. Aim
Autor:
Patrick Lacolley, Véronique Regnault, Marc Lambert, Philip G. de Groot, Hilde Kelchtermans, Emmanuel de Maistre, Zakera Shums, Nadine Magy-Bertrand, Vincent Poindron, Francis Guillemin, Virginie Dufrost, Gary L. Norman, Thomas Lecompte, Jessie Risse, Bas de Laat, Denis Wahl, Hélène Desmurs-Clavel, Stéphane Zuily
Publikováno v:
Journal of Applied Laboratory Medicine, 5(6), 1242-1252. American Association of Clinical Chemistry
The Journal of Applied Laboratory Medicine
The Journal of Applied Laboratory Medicine, Oxford University Press, 2020, 5 (6), pp.1242-1252. ⟨10.1093/jalm/jfaa072⟩
The Journal of Applied Laboratory Medicine
The Journal of Applied Laboratory Medicine, Oxford University Press, 2020, 5 (6), pp.1242-1252. ⟨10.1093/jalm/jfaa072⟩
Background Antibodies binding to domain I of β2-glycoprotein I (aDI) and activated protein C (APC) resistance are associated with an increased risk of thrombosis in cross-sectional studies. The objective of this study was to assess their predictive
Autor:
George N. Dalekos, Zakera Shums, Gary L. Norman, Nikolaos K. Gatselis, Roger Albesa, Tamas Tornai, Stella Gabeta, Mária Papp, Kalliopi Zachou, Asterios Saitis
Publikováno v:
World Journal of Gastroenterology
BACKGROUND Reliable biomarkers of cirrhosis, hepatocellular carcinoma (HCC), or progression of chronic liver diseases are missing. In this context, Golgi protein-73 (GP73) also called Golgi phosphoprotein-2, was originally defined as a resident Golgi
Autor:
Odette Viñas, Gary L. Norman, Maria A Romera, Silvia Ruiz-Gaspà, Mila Garcia, Zakera Shums, Albert Parés, Michael Mahler, Anna Reig, Chelsea Bentow
Publikováno v:
American Journal of Gastroenterology. 115:1634-1641
Introduction Antibodies to hexokinase 1 (HK1) and kelch-like 12 (KLHL12) have been identified as potential biomarkers in primary biliary cholangitis (PBC), and this study assesses changes of these antibodies over time and if they are associated with
Autor:
Danilo Villalta, Michael Mahler, Brunetta Porcelli, Andrea Seaman, Nicola Bizzaro, Chelsea Bentow, Gary L. Norman, Maria Alessio, Charles Warren, Marychel Tiongson
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 58:1499-1507
Background Anti-mitochondrial autoantibodies (AMA) detected by indirect immunofluorescence (IIF) on rodent tissues are the diagnostic marker of primary biliary cholangitis (PBC). However, up to 15% of patients with PBC are AMA-negative by IIF. In the
Autor:
Jialin Teng, Junna Ye, Qiongyi Hu, Liyan Wan, Yue Sun, Yutong Su, Xue-Feng Wang, Tingting Liu, Honglei Liu, Xiaobing Cheng, Jieyu Gu, Chengde Yang, Hui Shi, Jinfeng Zhou, Gary L. Norman
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-11 (2020)
Arthritis Research & Therapy
Arthritis Research & Therapy
Background Despite expansion in the 2006 Sydney antiphospholipid syndrome (APS) classification criteria to include IgG/IgM anti-β2-glycoprotein (aβ2GPI) antibodies in addition to IgG/IgM anti-cardiolipin antibodies (aCL) and lupus anticoagulant (LA
Autor:
Junna Ye, Jialin Teng, Tingting Liu, Jinchao Jia, Qiongyi Hu, Jing Dai, Zhihong Wang, Huihui Chi, Hui Shi, Honglei Liu, Yue Sun, Xinyao Wu, Chengde Yang, Liyan Wan, Yutong Su, Gary L. Norman, Jieyu Gu, Xiaobing Cheng, Jinfeng Zhou, Zhuochao Zhou
Publikováno v:
International Journal of Laboratory Hematology. 42:206-213
Introduction To assess the clinical performance and correlations of automated chemiluminescence assay (CIA) and enzyme-linked immunosorbent assay (ELISA) for detecting antiphospholipid (aPL) antibodies in the diagnosis of antiphospholipid syndrome (A
Autor:
Gary L. Norman, Satoru Joshita, Hiromi Saito, Eiji Tanaka, Masao Ota, Takeji Umemura, Kaname Yoshizawa
Publikováno v:
JHEP Reports
JHEP Reports, Vol 1, Iss 5, Pp 353-360 (2019)
JHEP Reports, Vol 1, Iss 5, Pp 353-360 (2019)
Background & Aims Natural killer (NK) cells are key participants in the innate immune response. Killer cell immunoglobulin-like receptors (KIRs) are involved in the activation and inhibition of NK cells through the recognition of human leukocyte anti
Autor:
Natalia Egri, Chelsea Bentow, Laura Rubio, Gary L. Norman, Susana López-Sañudo, Michael Mahler, Albert Pérez-Isidro, Ricard Cervera, Odette Viñas, Gerard Espinosa, Estíbaliz Ruiz-Ortiz
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
Patients with autoimmune diseases (ADs) are a challenge for the intensivist; it is hard to differentiate among infection, disease activity, and combinations of both, leading to high mortality. This study is a retrospective analysis of 124 critically
Autor:
Lazaros I. Sakkas, Christos Liaskos, Gary L. Norman, Dimitrios P. Bogdanos, Ioannis Alexiou, Christina G. Katsiari, S. Rentouli, Alexandros G. Brotis, A. Gkoutzourelas, Theodora Simopoulou
Publikováno v:
British Journal of Dermatology. 181:138-146
BACKGROUND Anti-C1q autoantibodies (autoAbs) are associated with systemic lupus erythematosus (SLE), but their presence in other rheumatic diseases has not been adequately investigated. OBJECTIVES We aimed to assess anti-C1q autoAbs and circulating i